Other mutated genes involved in the MAPK pathway include NF1, CBL, FGD6, FGFR2 and TRAF6 (17), among which, CBL (21), as a tumor suppressor, refers to E3 ubiquitin ligase with RING finger domain. The gene discussed is CBL; the disease is neoplasm.